ID   DPOD4_HUMAN             Reviewed;         107 AA.
AC   Q9HCU8; F5H506;
DT   26-SEP-2001, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   15-MAR-2017, entry version 132.
DE   RecName: Full=DNA polymerase delta subunit 4;
DE   AltName: Full=DNA polymerase delta subunit p12;
GN   Name=POLD4; Synonyms=POLDS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=10751307; DOI=10.1074/jbc.M001217200;
RA   Liu L., Mo J.-Y., Rodriguez-Belmonte E.M., Lee M.Y.W.T.;
RT   "Identification of a fourth subunit of mammalian DNA polymerase
RT   delta.";
RL   J. Biol. Chem. 275:18739-18744(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-39.
RG   NIEHS SNPs program;
RL   Submitted (FEB-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F.,
RA   Bloom T., Bruford E., Chang J.L., Cuomo C.A., Eichler E.,
RA   FitzGerald M.G., Jaffe D.B., LaButti K., Nicol R., Park H.-S.,
RA   Seaman C., Sougnez C., Yang X., Zimmer A.R., Zody M.C., Birren B.W.,
RA   Nusbaum C., Fujiyama A., Hattori M., Rogers J., Lander E.S.,
RA   Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   IDENTIFICATION IN POL-DELTA COMPLEX, INTERACTION WITH POLD1, AND
RP   CHARACTERIZATION OF POL-DELTA2 AND POL-DELTA4 COMPLEXES.
RX   PubMed=12403614; DOI=10.1021/bi0262707;
RA   Xie B., Mazloum N., Liu L., Rahmeh A., Li H., Lee M.Y.;
RT   "Reconstitution and characterization of the human DNA polymerase delta
RT   four-subunit holoenzyme.";
RL   Biochemistry 41:13133-13142(2002).
RN   [6]
RP   INTERACTION WITH POLDIP2.
RX   PubMed=12522211; DOI=10.1074/jbc.M208694200;
RA   Liu L., Rodriguez-Belmonte E.M., Mazloum N., Xie B., Lee M.Y.W.T.;
RT   "Identification of a novel protein, PDIP38, that interacts with the
RT   p50 subunit of DNA polymerase delta and proliferating cell nuclear
RT   antigen.";
RL   J. Biol. Chem. 278:10041-10047(2003).
RN   [7]
RP   INTERACTION WITH WRNIP1.
RX   PubMed=15670210; DOI=10.1111/j.1365-2443.2004.00812.x;
RA   Tsurimoto T., Shinozaki A., Yano M., Seki M., Enomoto T.;
RT   "Human Werner helicase interacting protein 1 (WRNIP1) functions as a
RT   novel modulator for DNA polymerase delta.";
RL   Genes Cells 10:13-22(2005).
RN   [8]
RP   UBIQUITINATION, AND MUTAGENESIS OF LYS-4; LYS-15; LYS-25; LYS-74 AND
RP   LYS-89.
RX   PubMed=16934752; DOI=10.1016/j.bbrc.2006.08.049;
RA   Liu G., Warbrick E.;
RT   "The p66 and p12 subunits of DNA polymerase delta are modified by
RT   ubiquitin and ubiquitin-like proteins.";
RL   Biochem. Biophys. Res. Commun. 349:360-366(2006).
RN   [9]
RP   FUNCTION, INTERACTION WITH POLD1; POLD2 AND PCNA, AND MUTAGENESIS OF
RP   ILE-7 AND 10-SER-TYR-11.
RX   PubMed=16510448; DOI=10.1074/jbc.M600322200;
RA   Li H., Xie B., Zhou Y., Rahmeh A., Trusa S., Zhang S., Gao Y.,
RA   Lee E.Y., Lee M.Y.;
RT   "Functional roles of p12, the fourth subunit of human DNA polymerase
RT   delta.";
RL   J. Biol. Chem. 281:14748-14755(2006).
RN   [10]
RP   UBIQUITINATION, DEGRADATION IN RESPONSE TO DNA DAMAGE, AND
RP   IDENTIFICATION IN POL-DELTA COMPLEX.
RX   PubMed=17317665; DOI=10.1074/jbc.M610356200;
RA   Zhang S., Zhou Y., Trusa S., Meng X., Lee E.Y., Lee M.Y.;
RT   "A novel DNA damage response: rapid degradation of the p12 subunit of
RT   dna polymerase delta.";
RL   J. Biol. Chem. 282:15330-15340(2007).
RN   [11]
RP   FUNCTION.
RX   PubMed=19074196; DOI=10.1093/nar/gkn1000;
RA   Meng X., Zhou Y., Zhang S., Lee E.Y., Frick D.N., Lee M.Y.;
RT   "DNA damage alters DNA polymerase delta to a form that exhibits
RT   increased discrimination against modified template bases and
RT   mismatched primers.";
RL   Nucleic Acids Res. 37:647-657(2009).
RN   [12]
RP   FUNCTION.
RX   PubMed=20334433; DOI=10.1021/bi100042b;
RA   Meng X., Zhou Y., Lee E.Y., Lee M.Y., Frick D.N.;
RT   "The p12 subunit of human polymerase delta modulates the rate and
RT   fidelity of DNA synthesis.";
RL   Biochemistry 49:3545-3554(2010).
RN   [13]
RP   SUBCELLULAR LOCATION, IDENTIFICATION IN POL-DELTA COMPLEX, INDUCTION
RP   BY UV, AND DEVELOPMENTAL STAGE.
RX   PubMed=22801543; DOI=10.4161/cc.21280;
RA   Chea J., Zhang S., Zhao H., Zhang Z., Lee E.Y., Darzynkiewicz Z.,
RA   Lee M.Y.;
RT   "Spatiotemporal recruitment of human DNA polymerase delta to sites of
RT   UV damage.";
RL   Cell Cycle 11:2885-2895(2012).
RN   [14]
RP   FUNCTION IN OKAZAKI FRAGMENT PROCESSING.
RX   PubMed=24035200; DOI=10.1016/j.dnarep.2013.08.008;
RA   Lin S.H., Wang X., Zhang S., Zhang Z., Lee E.Y., Lee M.Y.;
RT   "Dynamics of enzymatic interactions during short flap human Okazaki
RT   fragment processing by two forms of human DNA polymerase delta.";
RL   DNA Repair 12:922-935(2013).
RN   [15]
RP   UBIQUITINATION BY RNF8, AND INDUCTION BY UV.
RX   PubMed=23233665; DOI=10.1074/jbc.M112.423392;
RA   Zhang S., Zhou Y., Sarkeshik A., Yates J.R. III, Thomson T.M.,
RA   Zhang Z., Lee E.Y., Lee M.Y.;
RT   "Identification of RNF8 as a ubiquitin ligase involved in targeting
RT   the p12 subunit of DNA polymerase delta for degradation in response to
RT   DNA damage.";
RL   J. Biol. Chem. 288:2941-2950(2013).
RN   [16]
RP   UBIQUITINATION BY DTL, DEVELOPMENTAL STAGE, DEGRADATION IN RESPONSE TO
RP   DNA DAMAGE, AND MUTAGENESIS OF THR-8; ASP-9; LYS-15; ARG-16 AND
RP   ARG-17.
RX   PubMed=23913683; DOI=10.1074/jbc.M113.490466;
RA   Zhang S., Zhao H., Darzynkiewicz Z., Zhou P., Zhang Z., Lee E.Y.,
RA   Lee M.Y.;
RT   "A novel function of CRL4(Cdt2): regulation of the subunit structure
RT   of DNA polymerase delta in response to DNA damage and during the S
RT   phase.";
RL   J. Biol. Chem. 288:29550-29561(2013).
RN   [17]
RP   FUNCTION, INTERACTION WITH PCNA, INDUCTION BY UV, UBIQUITINATION BY
RP   DTL, AND MUTAGENESIS OF 1-MET--ARG-16; LYS-4; SER-10 AND LYS-15.
RX   PubMed=24022480; DOI=10.1074/jbc.C113.505586;
RA   Terai K., Shibata E., Abbas T., Dutta A.;
RT   "Degradation of p12 subunit by CRL4Cdt2 E3 ligase inhibits fork
RT   progression after DNA damage.";
RL   J. Biol. Chem. 288:30509-30514(2013).
RN   [18]
RP   INDUCTION BY IR AND UV, AND REVIEW.
RX   PubMed=24300032; DOI=10.4161/cc.27407;
RA   Lee M.Y., Zhang S., Lin S.H., Wang X., Darzynkiewicz Z., Zhang Z.,
RA   Lee E.Y.;
RT   "The tail that wags the dog: p12, the smallest subunit of DNA
RT   polymerase delta, is degraded by ubiquitin ligases in response to DNA
RT   damage and during cell cycle progression.";
RL   Cell Cycle 13:23-31(2014).
RN   [19]
RP   FUNCTION.
RX   PubMed=24310611; DOI=10.1126/science.1243211;
RA   Costantino L., Sotiriou S.K., Rantala J.K., Magin S., Mladenov E.,
RA   Helleday T., Haber J.E., Iliakis G., Kallioniemi O.P.,
RA   Halazonetis T.D.;
RT   "Break-induced replication repair of damaged forks induces genomic
RT   duplications in human cells.";
RL   Science 343:88-91(2014).
CC   -!- FUNCTION: As a component of the tetrameric DNA polymerase delta
CC       complex (Pol-delta4), plays a role in high fidelity genome
CC       replication and repair. Within this complex, increases the rate of
CC       DNA synthesis and decreases fidelity by regulating POLD1
CC       polymerase and proofreading 3' to 5' exonuclease activity
CC       (PubMed:16510448, PubMed:19074196, PubMed:20334433). Pol-delta4
CC       participates in Okazaki fragment processing, through both the
CC       short flap pathway, as well as a nick translation system
CC       (PubMed:24035200). Under conditions of DNA replication stress,
CC       required for the repair of broken replication forks through break-
CC       induced replication (BIR), a mechanism that may induce segmental
CC       genomic duplications of up to 200 kb (PubMed:24310611). Involved
CC       in Pol-delta4 translesion synthesis (TLS) of templates carrying
CC       O6-methylguanine or abasic sites (PubMed:19074196). Its
CC       degradation in response to DNA damage is required for the
CC       inhibition of fork progression and cell survival
CC       (PubMed:24022480). {ECO:0000269|PubMed:16510448,
CC       ECO:0000269|PubMed:19074196, ECO:0000269|PubMed:20334433,
CC       ECO:0000269|PubMed:24022480, ECO:0000269|PubMed:24035200,
CC       ECO:0000269|PubMed:24310611}.
CC   -!- SUBUNIT: Component of the tetrameric DNA polymerase delta complex
CC       (Pol-delta4), which consists of POLD1/p125, POLD2/p50,
CC       POLD3/p66/p68 and POLD4/p12, with POLD1 bearing DNA polymerase and
CC       3' to 5' proofreading exonuclease activities (PubMed:16510448,
CC       PubMed:17317665, PubMed:22801543). Within this complex, directly
CC       interacts with POLD1 and POLD2 (PubMed:12403614, PubMed:16510448).
CC       Directly interacts with PCNA, as do POLD1 and POLD3; this
CC       interaction stimulates Pol-delta4 polymerase activity
CC       (PubMed:24022480). As POLD1 and POLD2, directly interacts with
CC       WRNIP1; this interaction stimulates DNA polymerase delta-mediated
CC       DNA synthesis, independently of the presence of PCNA. This
CC       stimulation may be due predominantly to an increase of initiation
CC       frequency and also to increased processivity (PubMed:15670210).
CC       Upon genotoxic stress induced by DNA damaging agents or by
CC       replication stress, POLD4 is proteolytically degraded and Pol-
CC       delta4 is converted into a trimeric form of the complex (Pol-
CC       delta3) which has a increased proofreading activity
CC       (PubMed:22801543, PubMed:17317665). The DNA polymerase delta
CC       complex interacts with POLDIP2; this interaction is probably
CC       mediated through direct binding to POLD2 (PubMed:12522211).
CC       {ECO:0000269|PubMed:12403614, ECO:0000269|PubMed:12522211,
CC       ECO:0000269|PubMed:15670210, ECO:0000269|PubMed:16510448,
CC       ECO:0000269|PubMed:17317665, ECO:0000269|PubMed:22801543,
CC       ECO:0000269|PubMed:24022480}.
CC   -!- INTERACTION:
CC       P12004:PCNA; NbExp=4; IntAct=EBI-864968, EBI-358311;
CC       P28340:POLD1; NbExp=11; IntAct=EBI-864968, EBI-716569;
CC       P49005:POLD2; NbExp=3; IntAct=EBI-864968, EBI-372354;
CC       Q96S55:WRNIP1; NbExp=2; IntAct=EBI-864968, EBI-2513471;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:22801543}.
CC       Note=Partially recruited to DNA damage sites within 2 hours
CC       following UV irradiation, before degradation.
CC       {ECO:0000269|PubMed:22801543}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9HCU8-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9HCU8-2; Sequence=VSP_046864;
CC         Note=No experimental confirmation available.;
CC   -!- DEVELOPMENTAL STAGE: Expression is cell cycle-dependent, with
CC       highest levels in G2/M phase and a drastic drop in S phase
CC       (PubMed:22801543, PubMed:23913683). This trough may be mediated by
CC       DCX(DTL) E3 ubiquitin ligase complex (also called CRL4(CDT2))-
CC       mediated proteasomal degradation (PubMed:23913683).
CC       {ECO:0000269|PubMed:22801543, ECO:0000269|PubMed:23913683}.
CC   -!- INDUCTION: In response to DNA damage, genotoxic stress and
CC       replication stress, following UV irradiation, ionizing radiation,
CC       treatment with methyl methanesulfonate, hydroxyurea, or with
CC       aphidicolin, protein expression drops to undetectable levels, due
CC       to proteasomal degradation (PubMed:17317665, PubMed:22801543,
CC       PubMed:23233665, PubMed:23913683, PubMed:24300032). This down-
CC       regulation is ATR-dependent (PubMed:17317665).
CC       {ECO:0000269|PubMed:17317665, ECO:0000269|PubMed:22801543,
CC       ECO:0000269|PubMed:23233665, ECO:0000269|PubMed:23913683,
CC       ECO:0000269|PubMed:24300032}.
CC   -!- PTM: Ubiquitinated; undergoes 'Lys-48'-linked ubiquitination in
CC       response to UV irradiation, leading to proteasomal degradation
CC       (PubMed:17317665, PubMed:16934752, PubMed:23233665,
CC       PubMed:23913683). This modification is partly mediated by RNF8 and
CC       by the DCX(DTL) E3 ubiquitin ligase complex (also called
CC       CRL4(CDT2)) (PubMed:23233665, PubMed:24022480). Efficient
CC       degradation requires the presence of PCNA and is required for the
CC       inhibition of fork progression after DNA damage (PubMed:24022480).
CC       {ECO:0000269|PubMed:16934752, ECO:0000269|PubMed:17317665,
CC       ECO:0000269|PubMed:23233665, ECO:0000269|PubMed:23913683,
CC       ECO:0000269|PubMed:24022480}.
CC   -!- SIMILARITY: Belongs to the DNA polymerase delta subunit 4 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/pold4/";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF179890; AAG08966.1; -; mRNA.
DR   EMBL; AY928482; AAX09676.1; -; Genomic_DNA.
DR   EMBL; AP003419; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BG403692; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS58149.1; -. [Q9HCU8-2]
DR   CCDS; CCDS8158.1; -. [Q9HCU8-1]
DR   RefSeq; NP_001243799.1; NM_001256870.1. [Q9HCU8-2]
DR   RefSeq; NP_066996.3; NM_021173.4. [Q9HCU8-1]
DR   UniGene; Hs.523829; -.
DR   ProteinModelPortal; Q9HCU8; -.
DR   BioGrid; 121774; 8.
DR   IntAct; Q9HCU8; 7.
DR   STRING; 9606.ENSP00000311368; -.
DR   iPTMnet; Q9HCU8; -.
DR   PhosphoSitePlus; Q9HCU8; -.
DR   BioMuta; POLD4; -.
DR   EPD; Q9HCU8; -.
DR   MaxQB; Q9HCU8; -.
DR   PaxDb; Q9HCU8; -.
DR   PeptideAtlas; Q9HCU8; -.
DR   PRIDE; Q9HCU8; -.
DR   DNASU; 57804; -.
DR   Ensembl; ENST00000312419; ENSP00000311368; ENSG00000175482. [Q9HCU8-1]
DR   Ensembl; ENST00000539074; ENSP00000444780; ENSG00000175482. [Q9HCU8-2]
DR   GeneID; 57804; -.
DR   KEGG; hsa:57804; -.
DR   UCSC; uc001okm.5; human. [Q9HCU8-1]
DR   CTD; 57804; -.
DR   DisGeNET; 57804; -.
DR   GeneCards; POLD4; -.
DR   HGNC; HGNC:14106; POLD4.
DR   HPA; HPA071529; -.
DR   MIM; 611525; gene.
DR   neXtProt; NX_Q9HCU8; -.
DR   OpenTargets; ENSG00000175482; -.
DR   PharmGKB; PA33498; -.
DR   eggNOG; ENOG410J65P; Eukaryota.
DR   eggNOG; ENOG410XUCX; LUCA.
DR   GeneTree; ENSGT00390000005096; -.
DR   HOGENOM; HOG000031022; -.
DR   HOVERGEN; HBG057838; -.
DR   InParanoid; Q9HCU8; -.
DR   KO; K03505; -.
DR   OMA; EGPAGHC; -.
DR   OrthoDB; EOG091G10DR; -.
DR   PhylomeDB; Q9HCU8; -.
DR   TreeFam; TF103004; -.
DR   Reactome; R-HSA-110314; Recognition of DNA damage by PCNA-containing replication complex.
DR   Reactome; R-HSA-174411; Polymerase switching on the C-strand of the telomere.
DR   Reactome; R-HSA-174414; Processive synthesis on the C-strand of the telomere.
DR   Reactome; R-HSA-174417; Telomere C-strand (Lagging Strand) Synthesis.
DR   Reactome; R-HSA-174437; Removal of the Flap Intermediate from the C-strand.
DR   Reactome; R-HSA-5358565; Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha).
DR   Reactome; R-HSA-5358606; Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta).
DR   Reactome; R-HSA-5651801; PCNA-Dependent Long Patch Base Excision Repair.
DR   Reactome; R-HSA-5656169; Termination of translesion DNA synthesis.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5696397; Gap-filling DNA repair synthesis and ligation in GG-NER.
DR   Reactome; R-HSA-5696400; Dual Incision in GG-NER.
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-69091; Polymerase switching.
DR   Reactome; R-HSA-69166; Removal of the Flap Intermediate.
DR   Reactome; R-HSA-69183; Processive synthesis on the lagging strand.
DR   GeneWiki; POLD4; -.
DR   GenomeRNAi; 57804; -.
DR   PRO; PR:Q9HCU8; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000175482; -.
DR   CleanEx; HS_POLD4; -.
DR   ExpressionAtlas; Q9HCU8; baseline and differential.
DR   Genevisible; Q9HCU8; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0043625; C:delta DNA polymerase complex; IBA:GO_Central.
DR   GO; GO:0005739; C:mitochondrion; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:HPA.
DR   GO; GO:0003887; F:DNA-directed DNA polymerase activity; TAS:Reactome.
DR   GO; GO:0042769; P:DNA damage response, detection of DNA damage; TAS:Reactome.
DR   GO; GO:0006266; P:DNA ligation; TAS:Reactome.
DR   GO; GO:0006260; P:DNA replication; TAS:ProtInc.
DR   GO; GO:0000731; P:DNA synthesis involved in DNA repair; IBA:GO_Central.
DR   GO; GO:0006261; P:DNA-dependent DNA replication; IBA:GO_Central.
DR   GO; GO:0006298; P:mismatch repair; TAS:Reactome.
DR   GO; GO:0006297; P:nucleotide-excision repair, DNA gap filling; TAS:Reactome.
DR   GO; GO:0033683; P:nucleotide-excision repair, DNA incision; TAS:Reactome.
DR   GO; GO:0006296; P:nucleotide-excision repair, DNA incision, 5'-to lesion; TAS:Reactome.
DR   GO; GO:0000723; P:telomere maintenance; TAS:Reactome.
DR   GO; GO:0000722; P:telomere maintenance via recombination; TAS:Reactome.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0019985; P:translesion synthesis; TAS:Reactome.
DR   InterPro; IPR007218; DNA_pol_delta_4.
DR   Pfam; PF04081; DNA_pol_delta_4; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complete proteome; DNA damage; DNA excision;
KW   DNA repair; DNA replication; Nucleus; Polymorphism;
KW   Reference proteome; Ubl conjugation.
FT   CHAIN         1    107       DNA polymerase delta subunit 4.
FT                                /FTId=PRO_0000186051.
FT   MOTIF         1     16       PCNA-interaction protein motif (PIP box).
FT                                {ECO:0000269|PubMed:16510448,
FT                                ECO:0000269|PubMed:24022480}.
FT   VAR_SEQ      63    107       GITRLQRWCRAKQMGLEPPPEVWQVLKTHPGDPRFQCSLWH
FT                                LYPL -> VSGISIPYEAPRKTSCP (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_046864.
FT   VARIANT      39     39       R -> P (in dbSNP:rs28364240).
FT                                {ECO:0000269|Ref.2}.
FT                                /FTId=VAR_022269.
FT   VARIANT      59     59       G -> R (in dbSNP:rs34136263).
FT                                /FTId=VAR_057526.
FT   MUTAGEN       1     16       Missing: Complete loss of PCNA binding
FT                                and of degradation after UV irradiation.
FT                                {ECO:0000269|PubMed:24022480}.
FT   MUTAGEN       4      4       K->A: No effect on PCNA binding.
FT                                {ECO:0000269|PubMed:24022480}.
FT   MUTAGEN       4      4       K->Q: No effect on PCNA binding, nor on
FT                                degradation after UV irradiation; when
FT                                associated with Y-10. No effect on PCNA
FT                                binding, but normal degradation after UV
FT                                irradiation; when associated with Y-10
FT                                and A-15. {ECO:0000269|PubMed:24022480}.
FT   MUTAGEN       4      4       K->R: No effect on ubiquitination. Loss
FT                                of ubiquitination, when associated with
FT                                R-15, R-25, R-74 and R-89.
FT                                {ECO:0000269|PubMed:16934752}.
FT   MUTAGEN       7      7       I->A: Complete loss of PCNA binding; when
FT                                associated with 10-AA-11.
FT                                {ECO:0000269|PubMed:16510448}.
FT   MUTAGEN       8      8       T->A: Strongly increased stability
FT                                following UV irradiation; when associated
FT                                with A-9. {ECO:0000269|PubMed:23913683}.
FT   MUTAGEN       8      8       T->D: Complete loss of PCNA binding.
FT                                {ECO:0000269|PubMed:24022480}.
FT   MUTAGEN       9      9       D->A: Strongly increased stability
FT                                following UV irradiation; when associated
FT                                with A-8. {ECO:0000269|PubMed:23913683}.
FT   MUTAGEN      10     11       SY->AA: Complete loss of PCNA binding;
FT                                when associated with A-7.
FT                                {ECO:0000269|PubMed:16510448}.
FT   MUTAGEN      10     10       S->Y: No effect on PCNA binding, nor on
FT                                degradation after UV irradiation; when
FT                                associated with Q-4. No effect on PCNA
FT                                binding, but normal degradation after UV
FT                                irradiation with Q-4 and A-15.
FT                                {ECO:0000269|PubMed:24022480}.
FT   MUTAGEN      15     15       K->A: Decreased PCNA binding. No effect
FT                                on PCNA binding, but normal degradation
FT                                after UV irradiation; when associated
FT                                with Q-4 and Y-10. Increased stability
FT                                following UV irradiation and no trough
FT                                during S phase; when associated with A-16
FT                                and A-17. {ECO:0000269|PubMed:23913683,
FT                                ECO:0000269|PubMed:24022480}.
FT   MUTAGEN      15     15       K->R: No effect on ubiquitination. Loss
FT                                of ubiquitination; when associated with
FT                                R-4, R-25, R-74 and R-89.
FT                                {ECO:0000269|PubMed:16934752}.
FT   MUTAGEN      16     16       R->A: Increased stability following UV
FT                                irradiation and no trough during S phase;
FT                                when associated with A-15 and A-17.
FT                                {ECO:0000269|PubMed:23913683}.
FT   MUTAGEN      17     17       R->A: Increased stability following UV
FT                                irradiation and no trough during S phase;
FT                                when associated with A-15 and A-16.
FT                                {ECO:0000269|PubMed:23913683}.
FT   MUTAGEN      25     25       K->R: No effect on ubiquitination. Loss
FT                                of ubiquitination; when associated with
FT                                R-4, R-15, R-74 and R-89.
FT                                {ECO:0000269|PubMed:16934752}.
FT   MUTAGEN      74     74       K->R: No effect on ubiquitination. Loss
FT                                of ubiquitination; when associated with
FT                                R-4, R-15, R-25 and R-89.
FT                                {ECO:0000269|PubMed:16934752}.
FT   MUTAGEN      89     89       K->R: No effect on ubiquitination. Loss
FT                                of ubiquitination; when associated with
FT                                R-4, R-15, R-25 and R-74.
FT                                {ECO:0000269|PubMed:16934752}.
SQ   SEQUENCE   107 AA;  12433 MW;  6F412738E4D9A19C CRC64;
     MGRKRLITDS YPVVKRREGP AGHSKGELAP ELGEEPQPRD EEEAELELLR QFDLAWQYGP
     CTGITRLQRW CRAKQMGLEP PPEVWQVLKT HPGDPRFQCS LWHLYPL
//
